Send to a Friend Font Size: Increase Decrease

William Ackman

William Ackman's Portfolio

Ticker	# of Shares	Price	Value
GOOG	9,377,195	$343.34	$3,219,566,132
HLT	9,332,853	$329.31	$3,073,401,822
	15,095,528	$195.32	$2,948,458,529
QSR	23,348,135	$81.56	$1,904,273,891
LOW	7,468,850	$214.60	$1,602,815,210
HHC	16,570,228	$78.76	$1,305,071,158
GOOGL	2,185,000	$346.96	$758,107,600
CMG	953,608	$37.43	$35,693,548
View Additional Portfolio Information »

Bill Ackman runs hedge fund Pershing Square Capital, which he started in 2003 following the dissolution of Gotham Partners.

Ackman is a value investor with an activist bent. Activist investors agitate management for changes. He owns large positions in Target (NYSE: TGT) and Borders (NYSE: BGP). He has also been involved in activist situations at Wendy's (NYSE: WEN) and McDonald's (NYSE: MCD).

Ackman proved his acumen as a short seller in 2007/2008 as short positions he held in MBIA (NYSE: MBI) and Ambac (NYSE: ABK) proved to be big winners due to the credit crunch.

In July 2008, Ackman said he was short the common stock of Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE). Ackman also laid out a plan to reorganize the GSEs, which would wipe out the common shareholders.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Nov 16, 2015 06:38PM Prominent funds piled into Valeant ahead of tailspin
Nov 16, 2015 04:31PM Ackman's Pershing Square 13F Shows 43.37M Stake in Mondelez (MDLZ), Maintained Air Products (APD), Canadian Pacific (CP), Valeant (VRX)
Nov 11, 2015 04:23PM Ackman's Pershing Square Down 2.8% MTD, 21.2% YTD
Nov 11, 2015 03:01PM Valeant, Ackman must face U.S. insider trading lawsuit
Nov 9, 2015 05:32PM Market Wrap: OECD Warns on Trade Growth; Citron Selects New Target; DuPont Names New Chief
Nov 9, 2015 12:25PM Ackman says Valeant stock 'extraordinary bargain'
Nov 9, 2015 12:08PM Bill Ackman sees Valeant Pharma (VRX) de-levering dramatically over the next 18-24 months - Bloomberg
Nov 9, 2015 11:36AM Bill Ackman said Valeant Pharma (VRX) is its largest position
Nov 9, 2015 11:31AM Ackman Discuses Valeant Pharma (VRX) on Today's Call
Nov 9, 2015 11:26AM Bill Ackman says Zoetis (ZTS) extremely diversified
Nov 9, 2015 11:18AM Bill Ackman said Canadian Pacific Railway (CP) managed well through recent headwinds - Bloomberg
Nov 9, 2015 11:13AM Bill Ackman said Air Products (APD) can deliver EPS growth with cost controls
Nov 9, 2015 11:11AM Bill Ackman sees vast margin expansion at Mondelez (MDLZ)
Nov 9, 2015 08:20AM Ackman says Valeant likely to pay down debt in the next 18 months
Nov 6, 2015 10:08PM Valeant investors divided on fate of CEO Pearson
Nov 6, 2015 03:36PM Big bets on Valeant hit some hedge funds hard in October
Nov 6, 2015 08:37AM Goldman sold 1.3 million Valeant shares backing loan to CEO, Valeant says
Nov 5, 2015 06:29PM Pershing Square Holdings, Ltd. Releases Communication From Bill Ackman to Valeant Pharmaceuticals International CEO Mike Pearson
Nov 5, 2015 03:42PM Is a 'Fire Sale' in Store for Valeant Pharma (VRX)?
Nov 5, 2015 02:43PM Ackman, in email, says supports Valeant CEO Pearson
Nov 5, 2015 02:23PM Bill Ackman supports Valeant Pharma (VRX) CEO Pearson - CNBC
Nov 5, 2015 02:00PM FIRST ® Honors Michael Bloomberg, will.i.am, and Diana Lee Guzman for Advancing STEM Education in Underserved Communities During Inaugural FIRST, Inspire Award and Charity Event
Nov 5, 2015 12:29PM Herbalife (HLF) Gains on Anti-Ackman Trade
Nov 5, 2015 12:02PM Three Reasons Valeant (VRX) is Plunging Today
Nov 5, 2015 10:58AM Ackman backs Valeant CEO as shares tumble to 2-1/2 year lows
Nov 5, 2015 10:42AM Valeant (VRX) In Free Fall as Large Holders May Finally Be Crying Uncle
Nov 5, 2015 10:25AM Ackman Stocks Trade Lower on Valeant (VRX) Free-Fall
Nov 4, 2015 11:55AM Icahn Speculation Around Valeant (VRX) Grows Following Interview
Nov 3, 2015 03:47PM Hedge fund Marcato gains 8.4 percent in October: source
Nov 3, 2015 09:46AM Valeant's crisis fuels feud between Ackman and Australian fund manager Hempton
Nov 3, 2015 08:07AM Ackman's fund lost 7.3 percent in October, off 19 percent for year
Nov 2, 2015 09:27PM Bill Ackman's Pershing Square Down 19% YTD (VRX)
Nov 2, 2015 01:19PM Goldman Sachs says Valeant has long road ahead, cuts rating
Nov 2, 2015 12:18PM Citron's Left said "I have nothing with Bill Ackman. This is about Valeant (VRX)"
Nov 2, 2015 10:26AM Citron publishes no new allegations against Valeant, shares rise
Nov 1, 2015 07:32PM Citron Research: Don't Expect Anything Earth-Shattering on Valeant (VRX) Come Monday
Oct 30, 2015 06:18PM Ackman lecture no match for Citron tweet as Valeant tumbles anew
Oct 30, 2015 04:10PM Top 10 News for 10/26 - 10/30: Valeant's Saga Continues Marching Along; Walgreens Boots Moves to Acquire Rival
Oct 30, 2015 03:23PM Valeant Pharma (VRX) Trades Near Lows Heading Into Weekend
Oct 30, 2015 01:01PM Bill Ackman's conference call on Valeant Pharma (VRX) ends
Oct 30, 2015 12:57PM Valeant Pharmaceuticals (VRX) Bull-Bear Debate Rages
Oct 30, 2015 11:11AM Bill Ackman said their average cost on Valeant Pharma (VRX) is $186
Oct 30, 2015 10:23AM Bill Ackman Said Fund 'Fully Invested'; 'Scraped Together Funds' to Buy Recent 2M Shares
Oct 30, 2015 10:20AM Bill Ackman Compares Valeant Pharma (VRX) to American Express (AXP) in 1960s; Notes Buffett Bought on Panic
Oct 30, 2015 10:14AM Bill Ackman said Valeant Pharma (VRX) worth $180-$240 Near-Term, $262-$350 Long-Term
Oct 30, 2015 10:12AM Valeant (VRX) Trading at Less than 8X 2016 EPS Ex-Philidor - Ackman
Oct 30, 2015 10:08AM Bill Ackman calls Valeant (VRX) Bausch & Lombâ�� 'best in the business'
Oct 30, 2015 10:04AM Bill Ackman said the $100 million option on Philidor was for 'exclusivity' (VRX)
Oct 30, 2015 10:04AM Ackman: Valeant's main problem is PR, not fraud
Oct 30, 2015 09:26AM Amazon (AMZN) Should Distribute Drugs - Ackman

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed